Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antigen presentation and self-nonself discrimination.

L Adorini1

  • 1Preclinical Research, Sandoz Ltd., Basel, Switzerland.

Clinical Immunology and Immunopathology
|June 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Protective effect of UDCA against IL-11- induced cardiac fibrosis is mediated by TGR5 signalling.

Frontiers in cardiovascular medicine·2024
Same author

Farnesoid X receptor activation by the novel agonist TC-100 (3α, 7α, 11β-Trihydroxy-6α-ethyl-5β-cholan-24-oic Acid) preserves the intestinal barrier integrity and promotes intestinal microbial reshaping in a mouse model of obstructed bile acid flow.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2022
Same author

The FXR agonist obeticholic acid inhibits the cancerogenic potential of human cholangiocarcinoma.

PloS one·2019
Same author

Therapeutic effects of the selective farnesoid X receptor agonist obeticholic acid in a monocrotaline-induced pulmonary hypertension rat model.

Journal of endocrinological investigation·2019
Same author

Therapeutic effects of obeticholic acid (OCA) treatment in a bleomycin-induced pulmonary fibrosis rat model.

Journal of endocrinological investigation·2018
Same author

Differential effects of FXR or TGR5 activation in cholangiocarcinoma progression.

Biochimica et biophysica acta. Molecular basis of disease·2017
Same journal

Mechanisms of virus replication, persistence, and regulation of immune responses.

Clinical immunology and immunopathology·2020
Same journal

Cumulative subject index for volumes 86-89

Clinical immunology and immunopathology·1998
Same journal

D-penicillamine-induced pancreatic islet autoantibody production is independent of the immunogenetic background: a lesson from patients with Wilson's disease.

Clinical immunology and immunopathology·1998
Same journal

Characterization of gastric Na+/I- symporter of the rat.

Clinical immunology and immunopathology·1998
Same journal

CD8(+), radiosensitive T cells of parental origin, oppose cells capable of down-regulating cytotoxicity in murine acute lethal graft-versus-host disease.

Clinical immunology and immunopathology·1998
Same journal

Specific activity of alpha1proteinase inhibitor and alpha2macroglobulin in human serum: application to insulin-dependent diabetes mellitus.

Clinical immunology and immunopathology·1998
See all related articles

T cells distinguish self from non-self by recognizing peptide-MHC complexes. Blocking the MHC binding site presenting autoantigens may prevent autoimmune diseases.

Area of Science:

  • Immunology
  • Molecular Biology
  • Autoimmunity

Background:

  • T cell-mediated self-nonself discrimination is crucial for immune homeostasis.
  • This process relies on the presentation of self-peptides bound to Major Histocompatibility Complex (MHC) molecules.
  • Both T cell development (thymus) and peripheral T cell function involve continuous self-antigen presentation.

Purpose of the Study:

  • To elucidate the mechanisms of T cell self-nonself discrimination.
  • To explore the role of self-peptide-MHC complexes in T cell selection and autoimmunity.
  • To identify potential therapeutic targets for autoimmune diseases.

Main Methods:

  • The study is based on established immunological principles of T cell recognition and selection.
  • It involves analyzing the presentation of self-antigens by MHC molecules to T cells.

Related Experiment Videos

  • The premises lead to a proposed strategy for interfering with autoimmune induction.

    • Main Results:

    • T cell selection requires recognition of self-peptide-MHC complexes for both positive and negative selection.
    • Continuous processing and presentation of self-antigens are necessary for maintaining immune tolerance.
    • Autoimmunity arises when self-reactive T cells are activated by presented self-antigens or cross-reactive foreign antigens.

    Conclusions:

    • Interfering with the MHC binding site that presents autoantigens is a potential strategy to prevent autoimmune diseases.
    • Understanding self-antigen presentation is key to developing therapies for autoimmunity.
    • The continuous nature of self-nonself discrimination highlights the dynamic regulation of the immune system.